Marker Therapeutics inc (MRKR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MRKR Annual Balance Sheets →
The table below presents a historical view of Marker Therapeutics inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent11.33
Cash, Cash Equivalents Other10.70
Cash & Short-term Investments21.00
Other Receivables, Net, Current1.62
Interest Receivable, Current1.61
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.04
Total Current Assets14.59
Other Assets, Noncurrent0.00
Restricted Cash Current0.72
Total Assets14.59
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.02
Accrued Liabilities, Current0.12
Other Liabilities, Current1.28
Deferred Revenue, Current DE0.00
Total Current Liabilities2.42
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities2.42
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock476.34
Retained Earnings / Accumulated Deficit-464.19
Other Equity0.00
Common Stockholder's Equity12.17
Total Stockholder's Equity12.17
Liabilities & Stockholder's Equity14.59
4 historic quarters locked

Sign in to unlock the full Marker Therapeutics inc balance sheet history.

About Marker Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-097262

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.